(Rs. in Million) |
| Quarter ended | Year to Date | Year ended | |||||||
| 202603 | 202503 | % Var | 202603 | 202503 | % Var | 202603 | 202503 | % Var | |
| Sales | 5194.00 | 5524.00 | -5.97 | 17126.00 | 18598.00 | -7.91 | 17126.00 | 18598.00 | -7.91 |
| Other Income | 66.00 | 5.00 | 1220.00 | 123.00 | 50.00 | 146.00 | 123.00 | 50.00 | 146.00 |
| PBIDT | 1122.00 | 1240.00 | -9.52 | 2328.00 | 3335.00 | -30.19 | 2328.00 | 3335.00 | -30.19 |
| Interest | 146.00 | 179.00 | -18.44 | 621.00 | 752.00 | -17.42 | 621.00 | 752.00 | -17.42 |
| PBDT | 505.00 | 1061.00 | -52.40 | 856.00 | 2583.00 | -66.86 | 856.00 | 2583.00 | -66.86 |
| Depreciation | 420.00 | 377.00 | 11.41 | 1638.00 | 1344.00 | 21.88 | 1638.00 | 1344.00 | 21.88 |
| PBT | 85.00 | 684.00 | -87.57 | -782.00 | 1239.00 | -163.12 | -782.00 | 1239.00 | -163.12 |
| TAX | -61.00 | 181.00 | -133.70 | -295.00 | 330.00 | -189.39 | -295.00 | 330.00 | -189.39 |
| Deferred Tax | -41.00 | 8.00 | -612.50 | -275.00 | 30.00 | -1016.67 | -275.00 | 30.00 | -1016.67 |
| PAT | 146.00 | 503.00 | -70.97 | -487.00 | 909.00 | -153.58 | -487.00 | 909.00 | -153.58 |
| Equity | 247.00 | 247.00 | 0.00 | 247.00 | 247.00 | 0.00 | 247.00 | 247.00 | 0.00 |
| PBIDTM(%) | 21.60 | 22.45 | -3.77 | 13.59 | 17.93 | -24.19 | 13.59 | 17.93 | -24.19 |
| Company Name | CMP |
|---|---|
| Sun Pharma. Inds. | 1887.95 |
| Dr. Reddys Labs. | 1348.70 |
| Cipla | 1431.65 |
| Zydus Lifesciences | 1149.00 |
| Lupin | 2457.45 |
| View more.. | |
Start Research-backed Investing ...Now. Subscribe to Sapphire
MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.
To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.
MoneyWorks4Me ensures this through: